14 June 2024 : Clinical Research
Hemorrhagic Cysts in the Pancreas: Risk Factors, Treatment, and Outcomes – Insights from a Single-Center Study
Michał Serafin
1ABDEF*, Paulina Kluszczyk1ABDEF, Sebastian Maślanka 1ABCDE, Tomasz Kowalczyk1ABDEF, Beata Jabłońska 2ABDEF, Sławomir Mrowiec 2AEF
DOI: 10.12659/MSM.941955
Med Sci Monit 2024; 30:e941955
Table 2 Study group characteristics.
| Age (years) | 47±11 (28–61) |
| Female/Male | 0 (0%)/8 (100%) |
| Body mass index (BMI) | 22.35±3.31 (17.71–26.47) |
| 17.00–18.49 | 1 (12.5%) |
| 18.5–24.99 | 5 (62.5%) |
| 25–29.99 | 2 (12.5%) |
| Symptoms | |
| Abdominal pain | 5 (62.5%) |
| Nausea and vomiting | 2 (25%) |
| Melaena | 2 (25%) |
| Loss of appetite | 1 (12.5%) |
| Syncope | 1 (12.5%) |
| None | 1 (12.5%) |
| Comorbidities | |
| Portal hypertension | 3 (37.5%) |
| Hypertension | 2 (25%) |
| Diabetes | 2 (25%) |
| None | 2 (25%) |
| Drugs | |
| Alcohol | 1 (12.5%) |
| Cigarettes | 1 (12.5%) |
| Localisation of the cyst | |
| Head of pancreas | 1 (12.5%) |
| Body of pancreas | 1 (12.5%) |
| Tail of pancreas | 4 (50%) |
| Whole pancreas* | 1 (12.5%) |
| Body and tail of pancreas | 1 (12.5%) |
| Cyst etiology | |
| Acute pancreatitis | 5 (62.5%) |
| Chronic pancreatitis | 3 (37.5%) |
| American Society of Anesthesiologists (ASA) scale | |
| I | 0 (0%) |
| II | 2 (25%) |
| III | 4 (50%) |
| IV | 2 (25%) |
| Type of operation | |
| Marsupialization | 5 (62.5%) |
| Distal pancreatectomy | 3 (37.5%) |
| * Due to the large size of the cyst, it was not possible to determine its exact location. | |